Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lloyds Banking Group Plc American Depositary Shares (LYG) vs Summit Therapeutics Inc (SMMT) Price & Performance

Lloyds Banking Group Plc American Depositary SharesTrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Lloyds Banking Group Plc American Depositary Shares vs Summit Therapeutics Inc — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.39 (market cap $76.34B), while Summit Therapeutics Inc trades at $17.36 (market cap $13.71B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 5.6× Summit Therapeutics Inc's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.05% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 0 Days and Summit Therapeutics Inc for 16 Days on average.

LYGSMMT
Market Cap
$76.34B$13.71B
Volume
16,671,7336,173,057
Sector
FinancialsHealth
52-Week High
$6.28$26.38
52-Week Low
$4.42$12.43
Typical Hold Time
0 Days16 Days
Enterprise Value
$99.66B$13.04B
Dividend Yield
4.05%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lloyds Banking Group Plc American Depositary Shares

No Aura AI signal available yet.

Summit Therapeutics Inc

Summit Therapeutics (SMMT) trades at $17.29, down 3.68% on the day, amid a bullish technical signal driven by moving averages. The company reported no revenue and a net loss of $1.08 billion in 2025, with negative profitability ratios, but recent news of a $2 billion strategic investment from AstraZeneca and expanded clinical collaborations has boosted investor optimism.

The outlook is speculative, with significant upside potential based on the $29.33 analyst consensus price target, but high execution risk remains as the company is pre-revenue and reliant on clinical trial success. Key catalysts include upcoming trial results for ivonescimab, while risks involve drug development setbacks and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LYG
100% Buy0% Sell
Avg holding period · 0 Days
SMMT

No sentiment data available yet.

Top news

Latest headlines on both assets

About Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.

Read more on LYG →

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT →